SCHEMBL1891776

SCHEMBL1891776

CCCCCCCCCSC(O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.53
GPR84 Q9NQS5 11/20 0.50
FFAR1 O14842 2/20 0.50
MAPT P10636 2/20 0.48
HSD17B10 Q99714 2/20 0.48
GMNN O75496 1/20 0.48
TP53 P04637 1/20 0.48
POLB P06746 1/20 0.48
THRB P10828 1/20 0.48
CYP2C9 P11712 1/20 0.48
BLM P54132 1/20 0.48
PPARD Q03181 7/20 0.44
CES2 O00748 1/20 0.44
LCK P06239 1/20 0.44
ZDHHC20 Q5W0Z9 1/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44
PPARG P37231 6/20 0.41
PPARA Q07869 6/20 0.41
HDAC11 Q96DB2 5/20 0.41
TSHR P16473 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625100 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL11600198 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL29095829 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL1423545 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL197825 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL1405573 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL9833640 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL11600053 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL36143 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10
SCHEMBL1405319 1.00 EPHX1 (0.53) EPHX1GPR84FFAR1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-63063688-A None JP disclosed
EP-4567952-B1 CONDUCTIVE MATERIAL DISPERSION, CONDUCTIVE MATERIAL DISPERSION CONTAINING BINDER RESIN, SLURRY FOR ELECTRODE MEMBRANES, ELECTRODE MEMBRANE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY ARTIENCE CO LTD (JP) 2026-04-22 EP disclosed
US-12606440-B2 Carbon nanotube dispersion composition, mixture slurry, electrode film, and secondary battery ARTIENCE CO., LTD. (JP) 2026-04-21 US disclosed
US-12600878-B2 Topcoat layer, a lamination film containing the same, and a decorative article decorated by said lamination film BASF COATINGS GMBH (DE) 2026-04-14 US disclosed
US-20250346775-A1 TOPCOAT LAYER, A LAMINATION FILM CONTAINING THE SAME, AND A DECORATIVE ARTICLE DECORATED BY SAID LAMINATION FILM BASF COATINGS GMBH (DE) 2025-11-13 US disclosed
EP-4261255-B1 CONDUCTIVE MATERIAL DISPERSION AND USE OF CONDUCTIVE MATERIAL DISPERSION ARTIENCE CO LTD (JP) 2025-11-05 EP disclosed
US-20250256969-A1 CARBON NANOTUBE DISPERSION COMPOSITION, MIXTURE SLURRY, ELECTRODE FILM, AND SECONDARY BATTERY ARTIENCE CO., LTD. (JP) 2025-08-14 US disclosed
US-20250219080-A1 SLURRY FOR POSITIVE ELECTRODE FILM, POSITIVE ELECTRODE FILM, SECONDARY BATTERY, AND METHOD FOR PRODUCING POSITIVE ELECTRODE FILM ARTIENCE CO., LTD. (JP) 2025-07-03 US disclosed
EP-4578828-A1 CARBON NANOTUBE DISPERSION COMPOSITION, MIXTURE SLURRY, ELECTRODE FILM, AND SECONDARY BATTERY artience Co., Ltd. (JP) 2025-07-02 EP disclosed
EP-4567952-A2 CONDUCTIVE MATERIAL DISPERSION, CONDUCTIVE MATERIAL DISPERSION CONTAINING BINDER RESIN, SLURRY FOR ELECTRODE MEMBRANES, ELECTRODE MEMBRANE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY artience Co., Ltd. (JP) 2025-06-11 EP disclosed
US-20120302041-A1 Energy Ray-Curable Polymer, an Energy Ray-Curable Adhesive Composition, an Adhesive Sheet and a Processing Method of a Semiconductor Wafer LINTEC CORPORATION (JP) 2012-11-29 US disclosed
US-8304920-B2 Energy ray-curable polymer, an energy ray-curable adhesive composition, an adhesive sheet and a processing method of a semiconductor wafer LINTEC CORPORATION (JP) 2012-11-06 US disclosed
US-20110104874-A1 Energy Ray-Curable Polymer, an Energy Ray-Curable Adhesive Composition, an Adhesive Sheet and a Processing Method of a Semiconductor Wafer LINTEC CORPORATION (JP) 2011-05-05 US disclosed
US-20100233868-A1 Adhesive Sheet and a Processing Method of Semiconductor Wafer, and a Manufacturing Method of Semiconductive Chip LINTEC CORPORATION (JP) 2010-09-16 US disclosed
US-7160960-B2 Pressure sensitive adhesive composition and sheet, and adhered article TOYO INK MANUFACTURING CO., LTD. (JP) 2007-01-09 US disclosed
US-20050165146-A1 Pressure sensitive adhesive composition and sheet, and adhered article TOYO INK MANUFACTURING CO., LTD. (JP) 2005-07-28 US disclosed
US-5851662-A Adhesive sheet NEW OJI PAPER CO., LTD. (JP) 1998-12-22 US disclosed
EP-0745653-A1 PRESSURE-SENSITIVE ADHESIVE SHEET NEW OJI PAPER CO., LTD. (JP) 1996-12-04 EP disclosed
JP-S6363688-A PASSIVATING AGENT ON CATALYTIC CRACKING OF HYDROCARBON SAKAI CHEM IND CO LTD 1988-03-22 JP disclosed
US-RE29523-E Olefinic polymers stabilized with thioacyl trivalent phosphorus compounds BORG-WARNER CORPORATION (US) 1978-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600878-B2 Topcoat layer, a lamination film containing the same, and a decorative article decorated by said lamination film HHAT, HTR3D, EIF4A3 EPHX1 1121/4885GPR84 1248/4885FFAR1 3289/4885
US-12606440-B2 Carbon nanotube dispersion composition, mixture slurry, electrode film, and secondary battery ACP1, CCDC47, SEPTIN9 EPHX1 2026/4885GPR84 4533/4885FFAR1 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.